ATE447580T1 - Herstellungsverfahren für 2-substituierte derivate von östron und östradiol - Google Patents

Herstellungsverfahren für 2-substituierte derivate von östron und östradiol

Info

Publication number
ATE447580T1
ATE447580T1 AT05767940T AT05767940T ATE447580T1 AT E447580 T1 ATE447580 T1 AT E447580T1 AT 05767940 T AT05767940 T AT 05767940T AT 05767940 T AT05767940 T AT 05767940T AT E447580 T1 ATE447580 T1 AT E447580T1
Authority
AT
Austria
Prior art keywords
estrone
estradiol
production process
substituted derivatives
derivatives
Prior art date
Application number
AT05767940T
Other languages
English (en)
Inventor
Johannes Stoelwinder
Nicolaas Elisabeth Cornelis Moers
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of ATE447580T1 publication Critical patent/ATE447580T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C07J75/005—Preparation of steroids by cyclization of non-steroid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
AT05767940T 2004-08-04 2005-08-01 Herstellungsverfahren für 2-substituierte derivate von östron und östradiol ATE447580T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04103742 2004-08-04
PCT/EP2005/053732 WO2006013196A1 (en) 2004-08-04 2005-08-01 Process for the preparation 2-substituted-derivatives of estrone and estradiol

Publications (1)

Publication Number Publication Date
ATE447580T1 true ATE447580T1 (de) 2009-11-15

Family

ID=34929415

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05767940T ATE447580T1 (de) 2004-08-04 2005-08-01 Herstellungsverfahren für 2-substituierte derivate von östron und östradiol

Country Status (20)

Country Link
US (2) US7910756B2 (de)
EP (1) EP1776378B1 (de)
JP (1) JP5075626B2 (de)
KR (1) KR20070040386A (de)
CN (1) CN1993376A (de)
AR (1) AR050195A1 (de)
AT (1) ATE447580T1 (de)
AU (1) AU2005268768B2 (de)
BR (1) BRPI0514096A (de)
CA (1) CA2573133C (de)
DE (1) DE602005017500D1 (de)
EC (1) ECSP077228A (de)
ES (1) ES2334244T3 (de)
IL (1) IL180381A0 (de)
MX (1) MX2007001340A (de)
NO (1) NO20070747L (de)
RU (1) RU2007107914A (de)
TW (1) TW200611909A (de)
WO (1) WO2006013196A1 (de)
ZA (1) ZA200700483B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ300376B6 (cs) 2008-05-05 2009-05-06 Prírodovedecká Fakulta Uk Ligandy estrogenových receptoru alfa a beta, zpusob jejich prípravy a farmaceutické prostredky, které je obsahují
WO2012020417A1 (en) 2010-08-10 2012-02-16 Reliance Life Sciences Pvt. Ltd. Process for the preparation of estradiol and its derivatives
ES2671238T3 (es) * 2011-08-12 2018-06-05 Siemens Healthcare Diagnostics Inc. Detección de esteroides sexuales
CN104497088B (zh) * 2014-12-30 2016-08-24 湖南新合新生物医药有限公司 19-去甲-4-雄甾烯-3,17-二酮的制备方法
CN104592339A (zh) * 2014-12-30 2015-05-06 湖南新合新生物医药有限公司 雌甾-4,9-二烯-3,17-二酮的制备方法
ITUB20155260A1 (it) * 2015-10-30 2017-04-30 Ind Chimica Srl PROCESSO PER LA PREPARAZIONE DI 17?-idrossi-des-A-androst-9,10-en-5-one
CN108003210A (zh) * 2018-01-24 2018-05-08 四川理工学院 一种雌甾-4,9-二烯-3,17-二酮的制备方法
CN108997463B (zh) * 2018-08-09 2021-05-14 四川理工学院 一种雌甾-4，9-二烯-3，17-二酮制备方法
CN112409434B (zh) * 2020-11-27 2021-10-26 厦门欧瑞捷生物科技有限公司 一种去氢孕酮的合成方法
CN113861158B (zh) * 2021-11-22 2023-02-10 湖南新合新生物医药有限公司 一种合成甲基双烯双酮关键中间体的方法
CN114853802B (zh) * 2022-03-22 2023-11-28 河北康泰药业有限公司 一种谷内酯衍生物及其制备方法、药物组合物和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2997488A (en) * 1959-06-20 1961-08-22 Organon 2-methyl-19-nor-steroids
FR1468608A (fr) * 1960-08-04 1967-02-10 Upjohn Co 2-alpha-fluoro stéroïdes de la série de la 19-norandrostène et leur procédé d'obtention
FR1368721A (fr) * 1961-04-14 1964-08-07 Roussel Uclaf Dérivés de la 19-nor testostérone et procédé de préparation
CH409944A (fr) * 1961-04-14 1966-03-31 Roussel Uclaf Procédé de préparation de dérivés de la 19-nor-testostérone
US3519714A (en) 1966-03-15 1970-07-07 Herchel Smith Synthesis of gona-1,3,5(10)-trienes
US4400524A (en) * 1981-07-28 1983-08-23 The Upjohn Company Grignard reagents prepared from 5-halopentan-2-one propylene ketals
DE3208432A1 (de) * 1982-03-09 1983-09-15 The Upjohn Co., 49001 Kalamazoo, Mich. Verfahren zur herstellung von 19-norandrostendion, zwischenprodukt des 19-norandrostendions und verfahren zu seiner herstellung
US5504074A (en) 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
US5521168A (en) * 1994-10-13 1996-05-28 Alcon Laboratories, Inc. Estrogen metabolites for lowering intraocular pressure
US5998639A (en) 1995-11-06 1999-12-07 Akzo Nobel, N.V. Sulfatation of estrogen mixtures
IL119649A (en) * 1995-11-30 2002-03-10 Akzo Nobel Nv Preparation of Cyclic Kills of History - 3 keto- (5) 10, (-9) 11 steroidadians
US6051726A (en) 1997-03-13 2000-04-18 Pharm-Eco Laboratories, Inc. Synthesis of 2-alkoxyestradiols
AU7572600A (en) 1999-08-23 2001-03-19 Entremed, Inc Methods of obtaining 2-methoxyestradiol of high purity
US7087592B1 (en) 1999-08-23 2006-08-08 Entre Med, Inc. Compositions comprising purified 2-methoxyestradiol and methods of producing same
EP1343803A2 (de) 2000-11-27 2003-09-17 EntreMed, Inc. 2-substituierte estrogene mit antiangiogenischer aktivität

Also Published As

Publication number Publication date
EP1776378B1 (de) 2009-11-04
RU2007107914A (ru) 2008-09-10
US20090012319A1 (en) 2009-01-08
MX2007001340A (es) 2007-03-27
JP5075626B2 (ja) 2012-11-21
JP2008509109A (ja) 2008-03-27
ES2334244T3 (es) 2010-03-08
AU2005268768B2 (en) 2011-10-13
DE602005017500D1 (de) 2009-12-17
NO20070747L (no) 2007-04-23
AR050195A1 (es) 2006-10-04
ZA200700483B (en) 2008-09-25
CA2573133C (en) 2012-07-10
US20110152544A1 (en) 2011-06-23
BRPI0514096A (pt) 2008-05-27
AU2005268768A1 (en) 2006-02-09
CA2573133A1 (en) 2006-02-09
KR20070040386A (ko) 2007-04-16
EP1776378A1 (de) 2007-04-25
CN1993376A (zh) 2007-07-04
WO2006013196A1 (en) 2006-02-09
US7910756B2 (en) 2011-03-22
TW200611909A (en) 2006-04-16
IL180381A0 (en) 2007-06-03
ECSP077228A (es) 2007-03-29

Similar Documents

Publication Publication Date Title
ATE523508T1 (de) Für die behandlung von zellproliferativen erkrankungen geeignete pyridin- und pyrazinderivate
ATE432924T1 (de) 3-aminoindazole derivate und ihre verwendung zur behandlung sgk-bedingten krankheiten
EP2155203A4 (de) Azaindazol-verbindungen und anwendungsverfahren
ATE501721T1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
ATE545418T1 (de) Zusammensetzungen und kits zur behandlung von influenza
ATE390925T1 (de) Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen
NO20070753L (no) Fremgangsmåte for fremstilling av dihydropteridinoner
DK2426106T3 (da) Piperidin- og piperazinderivat til behandling af tumorer
ATE531720T1 (de) Aza-benzofuranylverbindungen und anwendungsverfahren dafür
ATE458732T1 (de) Verwendung von 4-imidazol-derivaten für zns- erkrankungen
ATE534633T1 (de) Indazolderivate zur behandlung von hsp90- induzierten krankheiten
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
EP1896083A4 (de) Verfahren zur behandlung von pompe-krankheit mit 1-desoxynojirimycin und derivaten
PL1951030T3 (pl) Udoskonalone sposoby i środki do wytwarzania hialuronianu
ATE505472T1 (de) Pyridinderivate und ihre verwendung bei der behandlung psychotischer erkrankungen
DE602007011906D1 (de) Tetrahydropyridothienpyrimidin-verbindungen und verwendung zur behandlung proliferativer erkrankungen
DE602007006019D1 (de) Für die behandlung von durch den gpr38-rezeptor vermittelten krankheiten geeignete piperazinylderivate
DE602005017636D1 (de) Neue hydantoinderivate zur behandlung von obstruktiven atemwegserkrankungen
ATE476414T1 (de) Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen
ME02017B (me) Jedinjenja, kompozicije i postupci za tretman beta-amiloidnih bolesti i sinukleinopatija
IL179758A0 (en) Substituted tetrahydro - 2h - isoquinolin - 1 - one derivatives, method for the production thereof, and use of the same as medicaments
DE602005013116D1 (de) Pyridin-verbindungen für die behandlung von prostaglandin-vermittelten krankheiten
DE602006001238D1 (de) Filter und dessen Herstellungsmethode
ZA200700483B (en) Process for the preparation 2-substituted-derivatives of estrone and estradiol
FI20095600L (fi) Koostumus ihosairauksien hoitoa varten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties